Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review. (2023)
Attributed to:
Developing a decision support tool to enable precision treatment of type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s43856-023-00359-w
PubMed Identifier: 37794166
Publication URI: http://europepmc.org/abstract/MED/37794166
Type: Journal Article/Review
Volume: 3
Parent Publication: Communications medicine
Issue: 1
ISSN: 2730-664X